Tweet
I haven't thought through whether this is a good thing or not, but first impression is that it may be a step in the correct direction.
The company, Johnson & Johnson, has proposed that Britain's national health care system reimburse use of the cancer drug Velcade, but only for people who benefit from the medicine. The company would refund any money spent on patients whose tumors don't shrink sufficiently after a trial treatment, which can cost $48,000 per patient.
Drug company offers money-back guarantee on cancer treatment in Britain - International Herald Tribune
The company, Johnson & Johnson, has proposed that Britain's national health care system reimburse use of the cancer drug Velcade, but only for people who benefit from the medicine. The company would refund any money spent on patients whose tumors don't shrink sufficiently after a trial treatment, which can cost $48,000 per patient.
Drug company offers money-back guarantee on cancer treatment in Britain - International Herald Tribune
Comment